key: cord-0911927-utayjpe6
authors: Jones, Christopher R.; Hamilton, Fergus W.; Thompson, Ameeka; Morris, Tim T.; Moran, Ed
title: SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: A sociodemographic analysis
date: 2020-12-01
journal: J Infect
DOI: 10.1016/j.jinf.2020.11.036
sha: c6026b3c05fc74cfa332656285a80b6666d69569
doc_id: 911927
cord_uid: utayjpe6

• Nosocomial transmission of SARS-CoV-2 between healthcare workers is evident. • Ethnicity is associated with SARS-CoV-2 antibody seroprevalence. • Socioeconomic factors influence risk of infection with SARS-CoV-2. • SARS-CoV-2 screening strategies must adapt to local healthcare contexts. • Collider bias can affect the interpretation of observational cohort data.

We read with interest Blairon et al's (1) analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence in a Belgian single centre study of 1499 healthcare workers (HCWs). The authors report 14.6% seroprevalence overall, with allied healthcare professionals (19.2%) and maintenance staff/technical services (16.4%) the worst affected. Many published studies on SARS-CoV-2 have been based on selected samples and are therefore at risk of selection bias induced by non-random testing patterns amongst volunteers (2) . Here we present a nested cross-sectional study to obtain seroprevalence results amongst HCWs and support staff at North Bristol NHS Trust that are robust to selection bias.

All staff employed between January-June 2020 were invited for voluntary testing using either: 1) the Abbott™ SARS-CoV-2 IgG chemiluminescent microparticle assay (Abbott Laboratories); or 2) the Roche™ Elecsys® Anti-SARS-CoV-2 (IgG/IgM) electrochemiluminescent immunoassay (Roche Diagnostics). Results were cross-referenced with selected information extracted from employee records. Staff postcodes were aggregated to Middle Layer Super Output Areas (MSOA) to investigate spatial variation in testing uptake and seroprevalence. We used Index of Multiple Deprivation (IMD) as a proxy for socioeconomic position. Data were first analysed according to testing status to determine selection into the testing sample.

We subsequently used inverse probability weighting (IPW) to standardise the tested sample to the full workforce. We used weighted regression to estimate associations between risk factors and SARS-CoV-2 seroprevalence. All analyses were performed using R (Version 4.0.0). Data were compared across groups using chi-square test of independence or Wilcoxon rank-sum test. Ethical approval for this study was granted by the North West -Greater Manchester West Research Ethics Committee (20/NW/0354).

Of the 12,254 HCWs and support staff registered during the study period, 6861 (56%) underwent SARS-CoV-2 antibody testing. Three cases were excluded due to incomplete data. Older age groups were more likely to present for testing, with those aged 51-60 (63%) and 61-70 (62%) the most likely; females (58%) were more likely to present than males (49%); White individuals (58%) were more likely to present than Black, Asian, and Minority Ethnic (BAME) (52%); and permanent staff (67%) were more likely to present than bank staff (19%) (all p<0.001). Attendance for testing ranged from 51% in the most deprived decile to 60% in the least deprived (p=0.001 for trend). Testing was similar across frontline and non-patient facing roles (p=0.11).

The overall rate of SARS-CoV-2 seroprevalence among tested HCWs and support staff was 9.3% (638/6858) ( Table 1) . BAME individuals were more likely to be seropositive than White (14.6% versus 8.2%, respectively; p<0.001). Seroprevalence was similar between females and males (9.3% versus 9.2%, respectively; p=0.9).

Seroprevalence generally decreased with age, being highest in those aged ≤20y (12.3%) and lowest in those aged ≥71y (5.9%) (p for trend <0.001). Seroprevalence ranged from 12.0% in the most deprived IMD decile to 8.4% in the least deprived (p<0.01). Staff SARS-CoV-2 seroprevalence at the MSOA level was weakly correlated with Public Health England case rate per 100,000 population (r=0.18).

Staff seroprevalence in the intensive care unit was 2.5% and it was 16.2% in the acute medical unit. We found 13.6% (respiratory ward) and 20.9% (elderly care) seroprevalence on the two designated COVID-19 inpatient wards. We found high seroprevalence in staff working in wards that experienced outbreaks -50% on an elderly care step-down ward and 52.4% on a cardiology ward.

Seroprevalence was higher in BAME than White individuals across all staff groups except for Medical/Dental, where the trend was reversed (4.4% BAME versus 9.6% White). The median IMD decile for BAME staff was 4 (IQR: 2, 7) and for White staff was 7 (IQR: 4, 9) . When restricting to medical and dental staff only, the median IMD decile for BAME staff (8; IQR: 4, 9) and for White staff (8; IQR: 6, 9) were similar. Studies in other centres have consistently shown higher rates of seroprevalence in HCWs -London (31.6%) (3), Birmingham (24.4%) (4), and Oxford (11%) (5) . As expected, working within areas of the hospital that provided care to acutely unwell patients was associated with higher rates of seroprevalence. However, in contrast to findings from a Danish study of HCWs (6), seroprevalence did not associate with wards designated for COVID-19 cohorting. As observed elsewhere (4), seroprevalence rates were low in the intensive care unit, where infection risk was likely mitigated by enhanced PPE use and probable reduced infectivity of cases that had progressed to the characterised immune-mediated disease phase. We found the highest seroprevalence rates in wards with known nosocomial outbreaks. Further supporting a role for transmission between staff groups, administrative and clerical staff (frequent contact with clinical staff) had higher seroprevalence than healthcare scientists (infrequent contact with clinical staff).

Our data highlight the complex interplay between biological, social, and economic factors that determine risk of infection during a pandemic. Identifying HCWs at increased risk of infection with SARS-CoV-2 will support the implementation of targeted interventions designed to ensure the entire workforce is protected during future COVID-19 outbreaks. As hospitals consider routine staff PCR testing for SARS-CoV-2 they should account for the decreased uptake in certain staff groups and ensure equity as much as possible.

Iversen K, Bundgaard H, Hasselbalch RB, Kristensen JH, Nielsen PB, Pries-Heje M, et al. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Lancet Infect Dis. 2020:S1473-3099(20)30589-2. Administrative groups de-identified to preserve anonymity. These groups share a common exposure riskthey are office-based and do not routinely have contact with clinical areas. 2 The percentages do not total 100% as we removed one row to preserve anonymity. 

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak

Collider bias undermines our understanding of COVID-19 disease risk and severity

Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust

SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study

Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study

We are grateful to North Bristol NHS Trust staff for their participation and providing data. We are grateful to Benjamin Pope for his technical support during this project.

None declared.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.